U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women

Christian C Faaborg-Andersen1,2, Chang Liu2,3, Veerappan Subramaniyam4

  • 1Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.

Insights

Both very low and very high levels of Apolipoprotein A1 (ApoA1) are linked to increased cardiovascular and all-cause mortality, indicating a U-shaped risk relationship in a large UK Biobank study.

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Biochemistry

Background:

  • Apolipoprotein A1 (ApoA1) is the primary protein in high-density lipoprotein (HDL).
  • Low HDL cholesterol (HDL-C) is a known cardiovascular risk factor.
  • Recent research suggests very high HDL-C levels may also increase mortality risk.

Purpose of the Study:

  • To examine the sex-specific association between elevated ApoA1 levels and adverse health outcomes.
  • To investigate the genetic underpinnings of these associations.
  • To clarify the relationship between ApoA1, HDL-C, and mortality risk.

Main Methods:

  • Prospective cohort study utilizing the UK Biobank.
  • Analysis of serum ApoA1 levels as the primary exposure.
  • Tracking cardiovascular and all-cause mortality as primary and secondary outcomes.

Main Results:

  • A U-shaped relationship was observed between ApoA1 levels and mortality in 402,783 participants over 12.1 years.
  • The highest ApoA1 decile showed increased cardiovascular and all-cause mortality compared to the lowest risk decile.
  • This U-shaped pattern was present in both sexes, more pronounced in men, and not fully explained by genetics or alcohol intake.

Conclusions:

  • Both very low and very high ApoA1 levels are associated with increased cardiovascular and all-cause mortality.
  • The findings highlight a complex, non-linear relationship between ApoA1 and mortality risk.
  • Further research is needed to understand the mechanisms driving this U-shaped association.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
284
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
37
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
249
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
636
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46